An­dreessen drums up a $450M fund to back their vi­sion for en­gi­neer­ing bi­ol­o­gy

Im­age: Vi­jay Pande, An­dreessen Horowitz.

An­dreessen Horowitz be­lieves that AI and ma­chine learn­ing are cre­at­ing a new biotech world with a lot less guess­work in­volved. And to­day they have a fresh $450 mil­lion fund to in­vest in the emerg­ing field.

Two years ago, Stan­ford’s Vi­jay Pande took the first step with a $200 mil­lion in­au­gur­al fund. Then a few months ago Jorge Conde joined as a new part­ner in the small group, sig­nal­ing to­day’s an­nounce­ment. Conde jumped to An­dreessen from Sy­ros, where he was chief strat­e­gy of­fi­cer. And he got out just ahead of a dis­as­trous pre­sen­ta­tion a few days ago at ASH on weak re­sults for their lead drug, which tanked the stock.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER